Clinical Trials 667 Views Ilya Pharma completes patient recruitment in first-in-human Phase I trial Malin Otmani October 13, 2020 Ilya Pharma has completed recruitment …
Clinical Trials 339 Views Immunicum announces next safety and enrollment update for Phase Ib/II trial Malin Otmani October 6, 2020 Immunicum has announced that a …
Clinical Trials 387 Views Ultimovacs announces positive trial results Malin Otmani October 1, 2020 Ultimovacs has announced positive results …
Clinical Trials 344 Views Oncopeptides initiates US Expanded Access Program Malin Otmani October 1, 2020 Oncopeptides announces that the open-label …
Clinical Trials 502 Views PILA PHARMA announces positive trial results Malin Otmani September 28, 2020 PILA PHARMA has announced that …
Clinical Trials 467 Views Cantargia reports new trial results and presents next development steps Malin Otmani September 24, 2020 Cantargia has announced updated interim …
Clinical Trials 867 Views Lundbeck announces positive data from the COMPLETE study Malin Otmani September 24, 2020 Lundbeck announces a new study …
Clinical Trials 828 Views Results from the world’s largest study of cardiovascular disease in type 2 diabetes Malin Otmani September 24, 2020 Novo Nordisk has announced the …
Clinical Trials 412 Views Genmab and Seattle Genetics present new data Malin Otmani September 22, 2020 Genmab and Seattle Genetics has …
Clinical Trials 460 Views Galecto’s oral galectin-3 Inhibitor well tolerated in Phase 1 Malin Otmani September 17, 2020 Galecto’s oral small molecule galectin-3 …
Clinical Trials 504 Views Albireo trial meets primary endpoints Malin Otmani September 15, 2020 Albireo Pharma has announced positive …
Clinical Trials 556 Views AstraZeneca announces results from Fasenra trial Malin Otmani September 14, 2020 Results from the OSTRO Phase …
Clinical Trials 439 Views Positive results from Lundbeck’s Vyepti study Malin Otmani September 14, 2020 Lundbeck has announced results from …
Clinical Trials 459 Views Calliditas enrolls first patient in China in Phase 3 study Malin Otmani September 9, 2020 Calliditas Therapeutics has announced that …
Clinical Trials 339 Views Oncopeptides completes extended enrollment of Phase 3 study Malin Otmani September 8, 2020 Oncopeptides has announced that the …
Clinical Trials 231 Views Exact Therapeutics restarts Phase I study Malin Otmani September 8, 2020 Exact Therapeutics has announced that …